cellular
N |
• wild-type bone marrow-derived leukocyte rolling and tethering within endothelium-specific conditional knockout mouse cremaster venules, 4 h after intrascrotal injection with Il1b
|
• 36.3% reduction in extravasation of wild-type bone marrow-derived neutrophils into endothelium-specific conditional knockout mouse cremaster, 4 h after intrascrotal injection with Il1b
• 43% reduction in extravasation of wild-type bone marrow-derived neutrophils into endothelium-specific conditional knockout mouse peritoneum, 4 h after injection with thioglycollate
|
hematopoietic system
• 36.3% reduction in extravasation of wild-type bone marrow-derived neutrophils into endothelium-specific conditional knockout mouse cremaster, 4 h after intrascrotal injection with Il1b
• 43% reduction in extravasation of wild-type bone marrow-derived neutrophils into endothelium-specific conditional knockout mouse peritoneum, 4 h after injection with thioglycollate
|
immune system
• 36.3% reduction in extravasation of wild-type bone marrow-derived neutrophils into endothelium-specific conditional knockout mouse cremaster, 4 h after intrascrotal injection with Il1b
• 43% reduction in extravasation of wild-type bone marrow-derived neutrophils into endothelium-specific conditional knockout mouse peritoneum, 4 h after injection with thioglycollate
|
• reduced delayed-type hypersensitivity (DTH) reaction after injection of DNFB-treated wild-type bone marrow-derived T cells into DNFB-treated endothelium-specific conditional knockout mouse ears: 25% reduced T cell recruitment and 21.5% reduced ear swelling
|